Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: T3 - What do you think is the endgame?
T3
3
Dec 30, 2011 09:28PM
2
Dec 31, 2011 11:54AM
1
Dec 31, 2011 12:04PM
11
Dec 31, 2011 06:06PM
2
Dec 31, 2011 06:32PM
8
Dec 31, 2011 07:27PM

Dec 31, 2011 07:32PM

One possibility is that TPL, having built up cash assets via its CORE portfolio and maybe one or two "lesser" MMP deals, could acquire PTSC for 10c-15c (i.e. 2x to 3x current market value). At 10c a share that's $41M to find

Another possibility would be for TPL to merge into PTSC and take advantage of PTSC's tax loss carry-forward (which I haven't researched). This might be of benefit to PTSC shareholders IF the deal is structured to that end.

Either way puts MMP ownership in one place and strengthens the leverage against alleged infringers. It also eliminates the PTSC/PDS/TPL bickering (and extravagances) and may placate Chuck Moore. I can see how that would be the ultimate goal.

1
Jan 01, 2012 02:38PM
11
Jan 01, 2012 09:26PM
5
Jan 02, 2012 01:02PM
16
Jan 03, 2012 12:53PM
Share
New Message
Please login to post a reply